One of the first applications of tissue inhibitors of metalloproteinases in the context of antitumor and antimetastatic effects was the work of Schultz et al. Under in vitro conditions, recombinant human TIMP (rTIMP) inhibited invasion of murine melanoma cells B16-F10 through human amniotic membrane [144]. The gene discussed is TIMP1; the disease is melanoma.